Published in Biochem Pharmacol on January 01, 2005
Spectrin-based skeleton as an actor in cell signaling. Cell Mol Life Sci (2011) 1.00
Capturing changes in gene expression dynamics by gene set differential coordination analysis. Genomics (2011) 0.86
Phorbol 12-myristate 13-acetate inhibits P-glycoprotein-mediated efflux of digoxin in MDCKII-MDR1 and Caco-2 cell monolayer models. Acta Pharmacol Sin (2013) 0.81
The emerging role of protein kinase Cθ in cytoskeletal signaling. J Leukoc Biol (2012) 0.80
Protein profiling of formalin fixed paraffin embedded tissue: Identification of potential biomarkers for pediatric brainstem glioma. Proteomics Clin Appl (2008) 0.79
MeDiA: Mean Distance Association and Its Applications in Nonlinear Gene Set Analysis. PLoS One (2015) 0.75
Liposome-coated lipoplex-based carrier for antisense oligonucleotides. Cancer Biol Ther (2015) 0.75
A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma. PLoS One (2017) 0.75
A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer (2004) 1.96
Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study. J Clin Oncol (2012) 1.56
Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia. Blood (2012) 1.50
Role of rituximab in the first-line therapy of high-risk diffuse large B-cell lymphoma: a retrospective analysis by the Polish Lymphoma Research Group. Pol Arch Med Wewn (2015) 1.41
Hereditary ovarian cancer in Poland. Int J Cancer (2003) 1.30
Protein 4.1, a component of the erythrocyte membrane skeleton and its related homologue proteins forming the protein 4.1/FERM superfamily. Folia Histochem Cytobiol (2006) 1.29
Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study. Blood (2012) 1.09
The significance of Treg cells in defective tumor immunity. Arch Immunol Ther Exp (Warsz) (2008) 1.07
Human DHHC proteins: a spotlight on the hidden player of palmitoylation. Eur J Cell Biol (2011) 1.04
Repeated injections of PEG-PE liposomes generate anti-PEG antibodies. Cell Mol Biol Lett (2005) 1.03
IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma. Immunol Lett (2005) 0.97
Proinflammatory chemokine gene expression influences survival of patients with non-Hodgkin's lymphoma. Folia Histochem Cytobiol (2011) 0.96
New fluorescent sensors based on 1H-pyrazolo[3,4-b] quinoline skeleton. J Fluoresc (2010) 0.95
[Epithelial-mesenchymal transition in cancer progression]. Postepy Biochem (2009) 0.94
Immunoglobulin D myeloma--problems with diagnosing and staging (own experience and literature review). Leuk Lymphoma (2005) 0.92
TGF-beta1 gene polymorphisms influence the course of the disease in non-Hodgkin's lymphoma patients. Cytokine (2006) 0.91
Expression of complement regulatory proteins: CD46, CD55, and CD59 and response to rituximab in patients with CD20+ non-Hodgkin's lymphoma. Med Oncol (2009) 0.90
Expression of microRNA-331 can be used as a predictor for response to therapy and survival in acute myeloid leukemia patients. Biomark Med (2015) 0.90
Mapping of an ankyrin-sensitive, phosphatidylethanolamine/phosphatidylcholine mono- and bi-layer binding site in erythroid beta-spectrin. Biochem J (2004) 0.89
microRNAs: fine tuning of erythropoiesis. Cell Mol Biol Lett (2012) 0.89
Different susceptibilities to 1,25-dihydroxyvitamin D3-induced differentiation of AML cells carrying various mutations. Leuk Res (2009) 0.89
A common nonsense mutation of the BLM gene and prostate cancer risk and survival. Gene (2013) 0.89
Angiogenesis measured by expression of CD34 antigen in lymph nodes of patients with non-Hodgkin's lymphoma. Folia Histochem Cytobiol (2004) 0.87
Duplication of the Wolf-Hirschhorn syndrome critical region causes neurodevelopmental delay. Eur J Med Genet (2010) 0.87
The effect of statins on cancer cells--review. Tumour Biol (2015) 0.87
The soluble CTLA-4 receptor: a new marker in autoimmune diseases. Arch Immunol Ther Exp (Warsz) (2005) 0.87
Rafts--the current picture. Folia Histochem Cytobiol (2005) 0.86
Palmitoylation of MPP1 (membrane-palmitoylated protein 1)/p55 is crucial for lateral membrane organization in erythroid cells. J Biol Chem (2012) 0.86
Crk and ABI1: binary molecular switches that regulate abl tyrosine kinase and signaling to the cytoskeleton. Genes Cancer (2012) 0.86
Elevated YB-1 expression is a new unfavorable prognostic factor in non-Hodgkin's lymphomas. Anticancer Res (2011) 0.85
Relapse of acute lymphoblastic leukemia in children in the context of microarray analyses. Arch Immunol Ther Exp (Warsz) (2011) 0.85
Circulating sCD138 and some angiogenesis-involved cytokines help to anticipate the disease progression of early-stage B-cell chronic lymphocytic leukemia. Mediators Inflamm (2006) 0.85
Increased angiogenesis in cutaneous T-cell lymphomas. Pathol Oncol Res (2004) 0.85
Release of an ~55kDa fragment containing the actin-binding domain of β-spectrin by caspase-8 during FND-induced apoptosis depends on the presence of protein 4.1. Arch Biochem Biophys (2013) 0.83
Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia. Final report of the Polish Adult Leukemia Group (PALG CLL1). Med Sci Monit (2005) 0.83
A raft-associated species of phosphatidylethanolamine interacts with cholesterol comparably to sphingomyelin. A Langmuir-Blodgett monolayer study. PLoS One (2009) 0.83
Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival. Postepy Hig Med Dosw (Online) (2013) 0.83
The role of hydrophobic interactions in ankyrin-spectrin complex formation. Biochim Biophys Acta (2010) 0.83
The 22.5 kDa spectrin-binding domain of ankyrinR binds spectrin with high affinity and changes the spectrin distribution in cells in vivo. Protein Expr Purif (2008) 0.82
[Nasopharyngeal carcinoma coexistent with lymph node tuberculosis, diagnostic difficulties--case report]. Otolaryngol Pol (2005) 0.82
The CXCL12-3'A allele plays a favourable role in patients with multiple myeloma. Cytokine (2013) 0.82
Soluble TNF-α receptor I encoded on plasmid vector and its application in experimental gene therapy of radiation-induced lung fibrosis. Arch Immunol Ther Exp (Warsz) (2011) 0.82
Alterations in the expression of signal-transducing CD3 zeta chain in T cells from patients with chronic inflammatory/autoimmune diseases. Arch Immunol Ther Exp (Warsz) (2007) 0.82
(AC)n microsatellite polymorphism and 14-nucleotide deletion in exon 42 ankyrin-1 gene in several families with hereditary spherocytosis in a population of South-Western Poland. Ann Hematol (2006) 0.82
A three-way translocation of MLL, MLLT11, and the novel reciprocal partner gene MYO18A in a child with acute myeloid leukemia. Cancer Genet (2012) 0.82
IL-17F gene polymorphism is associated with susceptibility to acute myeloid leukemia. J Cancer Res Clin Oncol (2014) 0.82
Central nervous system prophylaxis with intrathecal liposomal cytarabine in diffuse large B-cell lymphomas. Pol Arch Med Wewn (2013) 0.81
Variations in suppressor molecule ctla-4 gene are related to susceptibility to multiple myeloma in a polish population. Pathol Oncol Res (2011) 0.81
The application of conventional cytogenetics, FISH, and RT-PCR to detect genetic changes in 70 children with ALL. Ann Hematol (2008) 0.81
[Effect of metals, benzene, pesticides and ethylene oxide on the haematopoietic system]. Med Pr (2005) 0.81
High CD74 expression correlates with ZAP70 expression in B cell chronic lymphocytic leukemia patients. Med Oncol (2013) 0.81
The effect of the lipid-binding site of the ankyrin-binding domain of erythroid beta-spectrin on the properties of natural membranes and skeletal structures. Cell Mol Biol Lett (2010) 0.81
Phospholipid-induced structural changes to an erythroid beta spectrin ankyrin-dependent lipid-binding site. Biochim Biophys Acta (2008) 0.81
A novel L1340P mutation in the ANK1 gene is associated with hereditary spherocytosis? Br J Haematol (2014) 0.81
VEGF and bFGF gene polymorphisms in patients with non-Hodgkin's lymphoma. Biomed Res Int (2013) 0.81
Comparison of positron emission tomography/computed tomography with classical contrast-enhanced computed tomography in the initial staging of Hodgkin lymphoma. Leuk Lymphoma (2014) 0.81
Increased percentage of CD8+CD28- suppressor lymphocytes in peripheral blood and skin infiltrates correlates with advanced disease in patients with cutaneous T-cell lymphomas. Postepy Hig Med Dosw (Online) (2009) 0.81
A risk of breast cancer in women - carriers of constitutional CHEK2 gene mutations, originating from the North - Central Poland. Hered Cancer Clin Pract (2014) 0.81
Structural insight into an ankyrin-sensitive lipid-binding site of erythroid beta-spectrin. Mol Membr Biol (2007) 0.80
31P MRS analysis of the phospholipid composition of the peripheral blood mononuclear cells (PBMC) and bone marrow mononuclear cells (BMMC) of patients with acute leukemia (AL). Cell Mol Biol Lett (2008) 0.80
[Expression of serum vascular endothelial growth factor correlates with clinical outcome in multiple myeloma]. Pol Arch Med Wewn (2003) 0.80
Do we already know how spectrin attracts ankyrin? Cell Mol Life Sci (2010) 0.80
CTLA-4 (CD152) gene polymorphism at position 49 in exon 1 in Graves' disease in a Polish population of the Lower Silesian region. Arch Immunol Ther Exp (Warsz) (2004) 0.80
The emerging role of protein kinase Cθ in cytoskeletal signaling. J Leukoc Biol (2012) 0.80
Premature cardiovascular mortality in lymphoma patients treated with (R)-CHOP regimen - a national multicenter study. Int J Cardiol (2013) 0.80
Positive correlation between cyclooxygenase-2 and ABC-transporter expression in non-Hodgkin's lymphomas. Oncol Rep (2009) 0.79
Spectrin-phospholipid interactions. Existence of multiple kinds of binding sites? Chem Phys Lipids (2006) 0.79
Gene expression signatures and ex vivo drug sensitivity profiles in children with acute lymphoblastic leukemia. J Appl Genet (2011) 0.79
High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease. Eur J Haematol (2009) 0.79
Attaching a spin to a protein -- site-directed spin labeling in structural biology. Acta Biochim Pol (2007) 0.79
Infectious complications in patients with acute myeloid leukemia treated according to the protocol with daunorubicin and cytarabine with or without addition of cladribine. A multicenter study by the Polish Adult Leukemia Group (PALG). Int J Infect Dis (2009) 0.79
Aggregation of spectrin and PKCtheta is an early hallmark of fludarabine/mitoxantrone/dexamethasone-induced apoptosis in Jurkat T and HL60 cells. Mol Cell Biochem (2010) 0.79
Expression, purification and functional characterization of recombinant human acyl-CoA-binding protein (ACBP) from erythroid cells. Acta Biochim Pol (2010) 0.79
Increased expression of metalloproteinase-2 and -9 (MMP-2, MMP-9), tissue inhibitor of metalloproteinase-1 and -2 (TIMP-1, TIMP-2), and EMMPRIN (CD147) in multiple myeloma. Hematology (2015) 0.78
[Expression of Fas receptor and soluble Fas ligand (sFasL) concentration in acute leukemia]. Pol Arch Med Wewn (2002) 0.78
A risk of essential thrombocythemia in carriers of constitutional CHEK2 gene mutations. Haematologica (2011) 0.78
Asymmetric dimethylarginine in hematological malignancies: a preliminary study. Leuk Lymphoma (2008) 0.78